PR Newswire Asia's news > Biotechnology

 < Previous page   |   Title only   |   Print    Next page > 
     
CELEBRATING 25 YEARS AND BEYOND OF LIFE AFTER ORGAN TRANSPLANTATION AT THE NATIONAL UNIVERSITY CENTRE FOR ORGAN TRANSPLANTATION
Honouring 35 patients who stand as inspiring examples of resilience, underscoring the long-term success of organ transplantation ...
2026-03-30T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
WuXi Biologics Honored with CDMO Leadership Awards for Ninth Consecutive Year
SHANGHAI , March 30, 2026 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has ...
2026-03-30T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Qyuns Therapeutics-B (02509) 2025 Revenue Surges Over 4-Fold; Adjusted Profit Reaches Approximately RMB356 Million, Turning a Profit Year-on-Year
TAIZHOU, China , March 30, 2026 /PRNewswire/ -- Qyuns Therapeutics-B (02509) announced its 2025 annual results. Revenue amounted to approximately RMB807 million, representing a 4.08-fold year-on-year ...
2026-03-30T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
AROA Biosurgery Completes Randomised Controlled Trial for Symphony™; Preliminary Read-Out indicates Primary Endpoint Met
AUCKLAND, New Zealand , March 30, 2026 /PRNewswire/ -- Aroa Biosurgery Limited today announced completion of its randomised controlled trial (RCT) evaluating Symphony, with a preliminary study read-out ...
2026-03-30T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Insilico Medicine Announces Global R&D Collaboration with Lilly
AI-driven collaboration includes an exclusive worldwide license for a portfolio of programs spanning multiple therapeutic areas. ...
2026-03-30T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Jyong Biotech Updates the Potential Clinical Benefits and Advantages of Its Plant-Derived Innovative Drug MCS®-2
TAIPEI , March 28, 2026 /PRNewswire/ -- Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driven biotechnology company dedicated to the development and ...
2026-03-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Internationally Acclaimed Forensic Scientist Dr. Henry C. Lee Dies, Leaving Remarkable Legacy
WEST HAVEN, Conn. , March 28, 2026 /PRNewswire/ -- World-renowned forensic scientist Dr. Henry C. Lee passed away peacefully on Friday, March 27, at his home in Henderson, Nevada, displaying remarkable ...
2026-03-28T    Biotechnology   Computer/Electronics   Education   Health Care/Hospital 
Akeso Reports Full-Year 2025 Financial Results
HONG KONG , March 27, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced its 2025 annual results, highlighting a year of comprehensive, strategic leaps ...
2026-03-27T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Insilico Medicine and Tenacia Biotechnology Expand AI-Driven CNS Collaboration with Deal Value Up to US$94.75 Million
CAMBRIDGE, Mass. , March 26, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, and Tenacia ...
2026-03-26T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Keymed Biosciences Announces 2025 Annual Results and Business Updates
BEIJING , March 26, 2026 /PRNewswire/ -- Keymed Biosciences (HKEX: 02162) announced its 2025 annual results. The year marked the company's 10th anniversary and a pivotal year in its transition from R&D ...
2026-03-26T    Biotechnology   Health Care/Hospital 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.